iqvia glp-1 prescriptions q3 2024 semaglutide tirzepatide Obesity Deep Dive: How Payer Control Shaped the Market How are Indian companies making

For patients who prefer pill-based treatments, or who struggle with injections, these findings represent important progress

this year, a 6-month study enrolling 250 people with BMIs of 30 or more is underway with a primary endpoint of weight loss

Expected results: improved skin texture and tone within 2-4 weeks, visible reduction in fine lines and wrinkles at 6-8 weeks, enhanced hair growth and thickness at 12+ weeks for those using it for hair loss

This 0.5 mg dose provides clinically meaningful improvements in glycaemic control and is often sufficient for achieving treatment targets, particularly when combined with lifestyle modifications and other glucose-lowering therapies

Hims & Hers shares jumped 30% today on the news